What is the recommended dose and administration method for 70/30 (Novolin 70/30, NPH/Regular) insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing and Administration Method for 70/30 Insulin

Premixed insulin 70/30 (Novolin 70/30, NPH/Regular) should be administered twice daily, with approximately two-thirds of the total daily dose given before breakfast and one-third before dinner, with typical starting doses of 0.3-0.5 units/kg/day for insulin-naive patients. 1

Dosing Recommendations

  • For insulin-naive patients or those on low insulin doses, start with a total daily dose of 0.3-0.5 units/kg/day, with lower doses for patients at higher risk of hypoglycemia (elderly, renal impairment, poor oral intake) 2
  • Distribute the total daily dose as approximately 2/3 before breakfast and 1/3 before dinner 1
  • For patients transitioning from other insulin regimens, maintain the same total daily dose initially but adjust the distribution to the 2/3 morning and 1/3 evening pattern 1
  • For patients already on higher insulin doses (≥0.6 units/kg/day), consider a 20% reduction in total daily dose to prevent hypoglycemia 2

Administration Method

  • Administer subcutaneously 30 minutes before meals 3, 4
  • Morning dose should be given before breakfast and evening dose before dinner 1
  • Consistent meal timing is particularly important with premixed insulin regimens to avoid hypoglycemia 1
  • Premixed insulin should be administered using either vials with insulin syringes or prefilled pens 2

Monitoring and Adjustment

  • Monitor blood glucose levels frequently during initiation and dose adjustments 1
  • Target both fasting and postprandial glucose levels 1
  • Adjust doses based on patterns in blood glucose readings:
    • If fasting hyperglycemia occurs, increase the evening dose 1
    • If pre-dinner hyperglycemia occurs, increase the morning dose 1
  • Consider adding a third dose before lunch if twice-daily dosing fails to achieve glycemic targets 5

Clinical Considerations

Advantages

  • Simpler regimen compared to basal-bolus therapy (fewer daily injections) 1
  • May provide better glycemic control than sliding scale insulin alone 6
  • Cost-effective option compared to multiple daily injection regimens 7

Limitations

  • Associated with higher risk of hypoglycemia compared to basal-bolus regimens in hospitalized patients 2
  • Less flexible than basal-bolus regimens for patients with variable meal timing or content 2
  • Not recommended for hospitalized patients due to unacceptably high rates of iatrogenic hypoglycemia 2

Common Pitfalls to Avoid

  • Avoid using the same dose for both morning and evening injections; the morning dose should typically be higher 1
  • Never convert on a 1:1 basis without adjusting the distribution of morning and evening doses when switching from other insulin regimens 1
  • Don't neglect monitoring during initiation or transition periods, as this is when hypoglycemia risk is highest 1
  • Avoid using premixed insulin in hospitalized patients where basal-bolus regimens show better outcomes 2

Special Populations

  • For patients receiving enteral nutrition, some guidelines suggest giving 70/30 mixed insulin with half at the start of the feed and the rest halfway through the feed, though data remain scarce 2
  • For patients with type 1 diabetes, premixed insulin alone is not appropriate and should not be used as monotherapy 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.